Effects of extract of green tea and ginseng on pancreatic beta cells and levels of serum glucose, insulin, cholesterol and triglycerides in rats with experimentally streptozotocin-induced diabetes: A histochemical and inununohistochemical study

Journal of Animal and Veterinary Advances

Volumn 9, Issue 1, 2010, Pages 102-107

  Karaca, Turan ^a   Yoruk, Mecit ^a   Yoruk, Ibrahim H ^a   Uslu, Sana ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Diabetes melhtus; Ginseng; Green tea; Hypoglycaemia; Pancreatic cell; Streptozotocm

Indexed keywords

EID: 77953748767     PISSN: 16805593     EISSN: 1993601X     Source Type: Journal    
DOI: 10.3923/javaa.2010.102.107     Document Type: Article

References (31)

1. Attele, A.S., Y.P. Zhou and J.T. Xie, 2002. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes, 51: 1851-1858.
2. Bravo, L., 1998. Polyphenols: Chemistry, dietary sources, metabolism and nutritional significance. Nutr. Rev., 56: 317-333.
3. Cemek, M., S. Kaga and N. Simsek et al, 2008. Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocm-induced diabetic rats. J. Nat. Med., 62: 284-293.
4. Cho, W.C.S., W.S. Chung and S.K.W. Lee et al, 2006. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-mduced diabetic rats. Eur. J. Pharmacol, 550: 173-179.
5. Coskun, O., M. Kanter, M. Korkmaz and S. Oter, 2005. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-mduced oxidative stress and [β-cell damage in rat pancreas. Pharmacol. Res., 51: 117-123.
6. Craig, W.J., 1999. Health-promoting properties of common herbs. Am. J. Clin. Nutr., 70: 491S-499S.
7. Crespy, V. and G. Williamson, 2004. A review of the health effects of green tea catechins in in vivo animal models. J. Nutr., 134: 3431S-3440S.
8. Dona, M., I. Dell'Aica and F. Calabrese et al, 2003. Neutrophil restraint by green tea: Inhibition of inflammation, associated angiogenesis and pulmonary fibrosis. J. Immunol., 170: 4335-4341.
9. Evans, J.S., G.C. Gerritsen, K. Mann and S.P. Owen, 1965. Antitumor and hyperglycemic activity of streptozotocm (NSC-37917) and its cofactor, U-15, 774. Cancer. Chemother. Rep., 48: 1-6.
10. Ihara, Y., S. Toyokuni and K. Uchida et al, 1999. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats a model of type 2 diabetes. Diabetes, 48: 927-932.
11. Kaneto, H., G. Xu and K.H. Song et al, 2001. Activation of the hexosamme pathway leads to deterioration of pancreatic [β-cell function through the induction of oxidative stress. J. Biol. Chem., 276 (33): 31099-31104.
12. Kanter, M., H. Uysal, T. Karaca and H. Ozdemir Sagmanligil, 2006. Depression of glucose levels and partial restoration of pancreatic [β-cell damage by melatonin in streptozotocin-induced diabetic rats. Arch. Toxicol, 80: 362-369.
13. Kanter, M., O. Coskun, A. Korkmaz and S. Oter, 2004. Effects of Nigella sativa on oxidative stress and [3-cell damage in streptozotocin-induced diabetic rats. Anat. Rec. Part A, 279: 658-691.
14. Katryar, S.K., M.S. Matsm, C.A. Elmets andH. Mukhtar, 1999. Polyphenolic antioxidant (-) - epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem. Photobiol., 69: 148.
15. Kiefer, D. and T. Pantuso, 2003. Panax ginseng. Am. Fam. Phys., 68: 1539-1542.
16. Manna, P., M. Sinha and P.C. Sil, 2009. Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways. Toxicology, 257: 53-63.
17. Miyazaki, T., 1989. Chemical structure and biological activity of polysaccharides. Tokyo: Asakura Publishing House, pp: 138-181.
18. Nogichi, H., 2007. Stem cells for the treatment of diabetes. Endocr. J, 54: 7-16.
19. Olajide, A.O., A.S. Awe, J.M. Makinde and O. Morebise, 1999. Evaluation of the anti-diabetic property of Morinda lucida leaves in streptozotocin diabetic rats. J. Pharm. Pharmacol., 51: 41-46.
20. Pushparaj, P., C.H. Tan, B.K.H. Tan, 2000. Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats. J. Ethnopharmacol., 72: 69-76.
21. Rakieten, N., M.L. Rakieten, M.V. Nadkarni, 1963. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer. Chemother. Rep., 29: 91-98.
22. Ryu, O.H., J. Lee and K.W. Lee et al, 2006. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res. Clin. Pr., 71: 356-358.
23. Saravanan, G., L. Pan and S. Venkateswaran, 2002. Effect of cogent db, a herbal drug, on plasma insulin and hepatic enzymes of glucose metabolism in experimental diabetes. Diabetes Obes. Metab., 4: 394-398.
24. Sato, T. and G. Miyata, 2000. The nutraceutical benefit, Parti: Green tea. Nutrition, 16: 315-317.
25. Szkudelski, T., 2001. The mechanism of alloxan and streptozotocin action in β-cells of the rat pancreas. Physiol. Res., 50: 537-546.
26. Tiedge, M., S. Lortz, J. Drinkgern and Lenzen, 1997. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes, 46: 1733-1742.
27. Vuksan, V., J.L. Sievenpiper and J. Wong et al, 2001. American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dosedependent manner in healthy individuals. Am. J. Clin. Nutr., 73: 753-758.
28. Wang, B.X., Q.L. Zhou and M. Yang et al, 2003. Hypoglycemic activity of ginseng glycopeptide. Acta Pharmacol. Sin, 24: 50-54.
29. Wesnes, K.A., T. Ward, A. McGinty and O. Petrini, 2000. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology, 152: 353-361.
30. Xie, J.T., C.Z. Wang, S. Kim and Yuan, 2005. The anti-hyperglycemic property of different ginseng partitions. Orient Pharm. Exp. Med., 5: 1-15.
31. Yang, M., B.X. Wang and Y.L. Imetal, 1990. Effects of ginseng polysaccharides on reducing blood glucose and liver glycogen. Acta Pharmacol. Sin, 11: 520-524.